Table 2. Multivariate analysis: hazard ratios for NT-proBNP and PF-4var.
Model | Independent predictors | Hazard ratio | CI | P-value |
Model 1 | Creatinine | 9.95 | 1.18–84.23 | 0.038 |
(clinical+NT-proBNP) | Beta-blockers | 0.23 | 0.07–0.71 | 0.010 |
NT-proBNP | 8.91 | 2.57–30.01 | 0.001 | |
Model 2 | Creatinine | 18.3 | 12.7–98.6 | 0.001 |
(clinical+PF-4var) | Beta-blockers | 0.28 | 0.10–0.79 | 0.015 |
PF-4var | 0.87 | 0.78–0.97 | 0.012 | |
Model 3 | Creatinine | 9.24 | 1.03–83.12 | 0.047 |
(clinical+NT- | Beta-blockers | 0.22 | 0.07–0.70 | 0.011 |
proBNP+PF-4var) | NT-proBNP | 8.37 | 2.22–31.61 | 0.002 |
PF-4var | 0.89 | 0.79–0.99 | 0.036 |